BackHarrow Overview
Harrow Inc

Harrow Target Price

Where could HROW trade next? Consensus target price: $45.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.6

Average Target Price

$45.0042.4% upside

1 analysts in the last 4 months

High: $45 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09Leerink Partners$4542.4% upsideOpen
2026-05-13Cantor FitzgeraldSteve Seedhouse$88178.5% upsideOpen
2026-03-18BTIGThomas Shrader$6399.4% upsideOpen
2026-03-04H.C. WainwrightYi Chen$70121.5% upsideOpen
2025-11-11Cantor Fitzgerald$94197.5% upsideOpen
2025-09-29Lake StreetThomas Flaten$70121.5% upsideOpen
2025-09-23Craig-HallumChase Knickerbocker$64102.5% upsideOpen
2025-08-13H.C. WainwrightYi Chen$64102.5% upsideOpen
2025-07-11Cantor FitzgeraldSteve Seedhouse$76140.5% upsideOpen
2024-10-18B.Riley FinancialSahil Kazmi$73131% upsideOpen
2024-10-04Lake StreetBrooks O'Neil$5574.1% upsideOpen
2024-08-09Craig-HallumChase Knickerbocker$4542.4% upsideOpen
2024-06-21Craig-HallumChase Knickerbocker$305.1% downsideOpen
2024-06-03Loop Capital MarketsBrooks O'Neil$2520.9% downsideOpen
2024-06-03Lake StreetBrooks O'Neil$2520.9% downsideOpen

Harrow (HROW) FAQ

Harrow (HROW) currently reports a target price of $45. Use the charts on this page to explore Harrow's target price history and peer comparisons.

Analysts' average 12-month price target for Harrow is $45, about 42.4% upside from the current share price of $31.6. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $45, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Harrow, and consider following HROW for alerts when major investors trade the stock.

Harrow is classified in the Healthcare sector. On target price, it currently shows $45. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HROW with unrelated industries.